Related Experiment Videos
Additional tests to differentiate Arcanobacterium haemolyticum and Actinomyces pyogenes
P Carlson1, E Eerola, S Kontiainen
1Department of Medical Microbiology, Aurora Hospital, Helsinki, Finland.
Summary
Differentiating Arcanobacterium haemolyticum and Actinomyces pyogenes is crucial. New biochemical tests, including the Voges-Proskauer reaction, and fatty acid analysis effectively distinguish these bacterial species in clinical microbiology.
Area of Science:
- Clinical microbiology
- Bacteriology
- Diagnostic testing
Background:
- Accurate differentiation of Arcanobacterium haemolyticum and Actinomyces pyogenes is essential for appropriate patient management.
- Current diagnostic methods may not always provide sufficient discriminatory power between these closely related species.
Purpose of the Study:
- To evaluate novel biochemical and gas-liquid chromatography (GLC) methods for differentiating Arcanobacterium haemolyticum from Actinomyces pyogenes.
- To identify simple and reliable tests for routine clinical laboratory use.
Main Methods:
- Utilized commercially available biochemical test panels and diagnostic tablets.
- Performed gas-liquid chromatography (GLC) analysis of cellular fatty acids.
- Assessed fermentation of xylitol and alpha-methyl-D-glucoside, Voges-Proskauer reaction, and tributyrate hydrolysis.
Main Results:
- Xylitol and alpha-methyl-D-glucoside fermentation, Voges-Proskauer reaction, and tributyrate hydrolysis proved effective in differentiating the two species.
- GLC analysis revealed significant differences in the cellular fatty acid profiles, particularly for 16:0, 18:2(9,12), and 18:1(9) fatty acids.
- The Voges-Proskauer test, available in tablet form, demonstrated high utility and ease of performance.
Conclusions:
- The combination of specific biochemical tests and GLC analysis provides robust differentiation between Arcanobacterium haemolyticum and Actinomyces pyogenes.
- The Voges-Proskauer test is a valuable and easily implementable addition to existing diagnostic protocols for these bacteria in clinical settings.